AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Templeton, A Dhall, GI Calder, A Gomez-Alzugaray, M Ho, PC Pretnar-Darovec, A Sikazwe, C Jun-Kang, C Prasad, RNV Bygdeman, M Kovacs, L Kavkasidze, G Li-Juan, S Van Look, PFA von Hertzen, H Noonan, E Ali, M Peregoudov, A Laperriere, N von Hertzen, H Grimes, D Ali, M
Citation: A. Templeton et al., Lowering the doses of mifepristone and gemeprost for early abortion: a randomised controlled trial, BR J OBST G, 108(7), 2001, pp. 738-742

Authors: Stromberg, I Tornqvist, N Johansson, S Bygdeman, M Almqvist, PM
Citation: I. Stromberg et al., Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons, MICROSC RES, 54(5), 2001, pp. 287-297

Authors: Dhall, GI Calder, A Gomez-Alzugaray, M Ho, PC Pretnar, AD Chen, JK Bygdeman, M Kovacs, L Kavkasidze, G Song, LJ Van Look, PFA von Hertzen, H Noonan, E Ali, M Peregoudov, A Laperriere, N Grimes, D Ali, M
Citation: Gi. Dhall et al., Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost - A randomized controlled trial, ACT OBST SC, 80(5), 2001, pp. 447-451

Authors: Wu, YM Gomez-Alzugaray, M Haukkamaa, M Ngoc, NTN Ho, PC Pretnar-Darovec, A Healy, DL Sotnikova, E Shah, RS Pavlova, NG Chen, JK Song, S Bygdeman, M Kovacs, L Khomassuridze, A Song, LJ Hamzaoui, R Alexaniants, S Van Look, PFA von Hertzen, H Piaggio, G Peregoudov, A Vucurevic, M Grimes, D
Citation: Ym. Wu et al., Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial, BR J OBST G, 107(4), 2000, pp. 524-530

Authors: Bygdeman, M Danielsson, KG Marions, L Swahn, ML
Citation: M. Bygdeman et al., Pregnancy termination, STEROIDS, 65(10-11), 2000, pp. 801-805

Authors: Bygdeman, M
Citation: M. Bygdeman, Profile of recruitment in Sweden, BEST P R CL, 13(3), 1999, pp. 383-386

Authors: Jordan, JA Bygdeman, M Templeton, A Symonds, EM Allen, I Stirrat, GN Rodeck, CH Regan, L O'Brien, PMS Pepperell, RJ
Citation: Ja. Jordan et al., Profile of recruitment in Sweden - Discussion, BEST P R CL, 13(3), 1999, pp. 387-392

Authors: Shaw, RW Drife, JO Rodeck, CH Biggs, JSG Symonds, EM Templeton, A Bygdeman, M Stirrat, GM
Citation: Rw. Shaw et al., Academic obstetrics and gynaecology in the 21st century - Discussion, BEST P R CL, 13(3), 1999, pp. 440-443

Authors: Jacobson, B Bygdeman, M
Citation: B. Jacobson et M. Bygdeman, Association between obstetric care and risk of suicide - Reply, BR MED J, 318(7192), 1999, pp. 1211-1212

Authors: Jacobson, B Bygdeman, M
Citation: B. Jacobson et M. Bygdeman, Authors defend methods used in their paper, BR MED J, 318(7185), 1999, pp. 737-737

Authors: Swahn, ML Bygdeman, M Chen, JK Gemzell-Danielsson, K Song, S Yang, QY Yang, PJ Qian, ML Chang, WF
Citation: Ml. Swahn et al., Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol, HUM REPR, 14(2), 1999, pp. 485-488

Authors: Marions, L Viski, S Danielsson, KG Resch, BA Swahn, ML Bygdeman, M Kovacs, L
Citation: L. Marions et al., Contraceptive efficacy of daily administration of 0.5 mg mifepristone, HUM REPR, 14(11), 1999, pp. 2788-2790

Authors: Danielsson, KG Marions, L Rodriguez, A Spur, BW Wong, PYK Bygdeman, M
Citation: Kg. Danielsson et al., Comparison between oral and vaginal administration of misoprostol on uterine contractility, OBSTET GYN, 93(2), 1999, pp. 275-280

Authors: Stenlund, PM Ekman, G Aedo, AR Bygdeman, M
Citation: Pm. Stenlund et al., Induction of labor with mifepristone - A randomized, double-blind study versus placebo, ACT OBST SC, 78(9), 1999, pp. 793-798

Authors: Lidegaard, O Bygdeman, M Milsom, I Nesheim, BI Skjeldestad, FE Toivonen, J
Citation: O. Lidegaard et al., Oral contraceptives and thrombosis - From risk estimates to health impact, ACT OBST SC, 78(2), 1999, pp. 142-149
Risultati: 1-15 |